Ronny Allan – Top 6 posts of 2017

Facebook
Twitter
Pinterest
WhatsApp
Email

These are my top performing posts for 2017 – comprising one eighth of my entire hits for the year.  My blog hits for 2017 almost reached a quarter of a million, double that of 2016 which was double that of 2015.  A chunk of these figures can be attributed to most of these articles.  Please share to maintain the momentum.

Top 6 posts for 2017 (Click on each article title to read)Short DescriptionHits in 2017
The Human Anatomy of Neuroendocrine CancerMaking the point that Neuroendocrine Cancer is not confined to a particular part of the body9,906
Neuroendocrine Cancer Syndromes – Early Signs of a Late DiagnosisAll about syndromes7,546
Neuroendocrine Neoplasms – Grade and Stage (incorporating WHO 2017 changes)The very latest information (particularly about grading)7,027
Neuroendocrine Cancer – no treats, just tricksA very powerful awareness message.  It was only published 2 months ago and is already the 10th most read post in over 220 since this site was set up.6,083
Steve Jobs – the most famous Neuroendocrine Cancer Ambassador we NEVER hadLove him or hate him, he generates external hits on my site – you could say he is now helping with Neuroendocrine Cancer awareness.  It also debunks the Pancreatic Cancer myth6,046
Ignore this post about Neuroendocrine CancerAnother very powerful awareness message – it is also the most tweeted post about NETs on twitter4,812

Thanks for reading.

Ronny

I’m also active on Facebook. Like my page for even more news. Help me build up my new site here – click here and ‘Like’

Sign up for my newsletters – Click Here

Disclaimer

My Diagnosis and Treatment History

Follow me on twitter

Check out my online presentations

Check out my WEGO Health Awards

Like my new awareness page – click here or on the photo.  (Like rather than follow please!)

Remember ….. in the war on Neuroendocrine Cancer, let’s not forget to win the battle for better quality of life!

patients included

Please Share this post for Neuroendocrine Cancer awareness and to help another patient

 
 
 
Facebook
Twitter
Pinterest
WhatsApp
Email

Prospective phase II trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT imaging of integrin for prognostication in patients with neuroendocrine neoplasms

August 25, 2022 — A new gallium-68 PET radiotracer appears effective for predicting higher risk of disease progression and mortality in patients with neuroendocrine tumors,

Read More »

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial

One of the most controversial subjects in Neuroendocrine Neoplasms is the management of small non-functional (asymptomatic) pancreatic NETs (NF-PanNEN).  In the most general terms, surgery

Read More »

Clinical Trial: Phase 1b/3 Targeted Alpha-Emitter PRRT RYZ101 (Ac225)

What is RYZ101? RYZ101 is an investigational targeted alpha-emitter radiopharmaceutical therapy, designed to deliver a highly potent radioisotope, Actinium-225 (Ac225), to tumors expressing SSTR2. RYZ101

Read More »

Neuroendocrine Cancer: When you get years added to your life, it’s important to get life added to your years

Self Pity or Self Help?  I’m not one for wallowing in self-pity or accepting invites to pity parties.  It’s not my style. Things happen in

Read More »

A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST)

A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST) Neuroendocrine

Read More »

2 thoughts on “Ronny Allan – Top 6 posts of 2017

I love comments - feel free!

%d bloggers like this: